GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer

Abstract Esophageal squamous cell carcinoma (ESCC) is notorious for its poor prognosis. In the present study, the role of glutaminase 2 (GLS2) and copper (Cu) in the radiosensitivity of ESCC was explored. Both in vitro and in vivo experiments were conducted, and the results demonstrated that the kno...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Jing, Wenhao Wang, Yi Ding, Renya Zeng, Hui Zhu, Zhichao Kang, Alei Feng, Zhe Yang
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-025-00653-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850184765252042752
author Wang Jing
Wenhao Wang
Yi Ding
Renya Zeng
Hui Zhu
Zhichao Kang
Alei Feng
Zhe Yang
author_facet Wang Jing
Wenhao Wang
Yi Ding
Renya Zeng
Hui Zhu
Zhichao Kang
Alei Feng
Zhe Yang
author_sort Wang Jing
collection DOAJ
description Abstract Esophageal squamous cell carcinoma (ESCC) is notorious for its poor prognosis. In the present study, the role of glutaminase 2 (GLS2) and copper (Cu) in the radiosensitivity of ESCC was explored. Both in vitro and in vivo experiments were conducted, and the results demonstrated that the knockdown of GLS2 could suppress cell proliferation and augment the sensitivity to radiotherapy (RT). The addition of Cu influenced cell viability and radiosensitivity. Notably, under normal GLS2 expression status, exogenous Cu augmented RT sensitivity without triggering cuproptosis. Mechanistically, the suppression of GLS2 interacted with Cu to downregulate lipoic acid synthase and dihydrolipoamide S-succinyltransferase, resulting in the reduction of the activity of α-ketoglutarate dehydrogenase complex and the obstruction of the tricarboxylic acid cycle, ultimately leading to the enhancement of RT sensitivity. These findings emphasize the significance of cuproptosis in ESCC radiotherapy and provide potential directions for therapeutic strategies.
format Article
id doaj-art-b0b62a4c211a4b3ca4bb37d3f1eebfc0
institution OA Journals
issn 2162-3619
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series Experimental Hematology & Oncology
spelling doaj-art-b0b62a4c211a4b3ca4bb37d3f1eebfc02025-08-20T02:16:56ZengBMCExperimental Hematology & Oncology2162-36192025-04-011411510.1186/s40164-025-00653-4GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancerWang Jing0Wenhao Wang1Yi Ding2Renya Zeng3Hui Zhu4Zhichao Kang5Alei Feng6Zhe Yang7Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Medical Oncology, Affiliated Hospital of Shandong Second Medical UniversityDepartment of Radiation Oncology, Shandong Provincial HospitalDepartment of Radiation Oncology, Shandong Provincial HospitalDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical UniversityDepartment of Radiation Oncology, Shandong Provincial HospitalDepartment of Radiation Oncology, Shandong Provincial HospitalDepartment of Radiation Oncology, Shandong Provincial HospitalAbstract Esophageal squamous cell carcinoma (ESCC) is notorious for its poor prognosis. In the present study, the role of glutaminase 2 (GLS2) and copper (Cu) in the radiosensitivity of ESCC was explored. Both in vitro and in vivo experiments were conducted, and the results demonstrated that the knockdown of GLS2 could suppress cell proliferation and augment the sensitivity to radiotherapy (RT). The addition of Cu influenced cell viability and radiosensitivity. Notably, under normal GLS2 expression status, exogenous Cu augmented RT sensitivity without triggering cuproptosis. Mechanistically, the suppression of GLS2 interacted with Cu to downregulate lipoic acid synthase and dihydrolipoamide S-succinyltransferase, resulting in the reduction of the activity of α-ketoglutarate dehydrogenase complex and the obstruction of the tricarboxylic acid cycle, ultimately leading to the enhancement of RT sensitivity. These findings emphasize the significance of cuproptosis in ESCC radiotherapy and provide potential directions for therapeutic strategies.https://doi.org/10.1186/s40164-025-00653-4CuproptosisEsophageal cancerRadiotherapyCancer metabolismGLS2
spellingShingle Wang Jing
Wenhao Wang
Yi Ding
Renya Zeng
Hui Zhu
Zhichao Kang
Alei Feng
Zhe Yang
GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
Experimental Hematology & Oncology
Cuproptosis
Esophageal cancer
Radiotherapy
Cancer metabolism
GLS2
title GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
title_full GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
title_fullStr GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
title_full_unstemmed GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
title_short GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer
title_sort gls2 inhibition synergizes with copper to reprogram tca cycle for cuproptosis driven radiosensitization in esophageal cancer
topic Cuproptosis
Esophageal cancer
Radiotherapy
Cancer metabolism
GLS2
url https://doi.org/10.1186/s40164-025-00653-4
work_keys_str_mv AT wangjing gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT wenhaowang gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT yiding gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT renyazeng gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT huizhu gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT zhichaokang gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT aleifeng gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer
AT zheyang gls2inhibitionsynergizeswithcoppertoreprogramtcacycleforcuproptosisdrivenradiosensitizationinesophagealcancer